Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasis

Published:2022-03 Issue:8 Volume:125 Page:1218-1223
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:Journal of Surgical Oncology

Author:

McCaffrey Rachel L¹^ORCID,Thompson Jessica L²,Oudsema Rebecca H³,Sciallis Andrew P⁴,Cobain Erin F⁵,Sabel Michael S²^ORCID,Jeruss Jacqueline S²

Affiliation:

1. Department of Surgery Vanderbilt University Nashville Tennessee USA

2. Department of Surgery University of Michigan Ann Arbor Michigan USA

3. Department of Radiology University of Michigan Ann Arbor Michigan USA

4. Department of Pathology University of Michigan Ann Arbor Michigan USA

5. Department of Oncology University of Michigan Ann Arbor Michigan USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26840

Reference29 articles.

1. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

3. HER2+ Breast Cancer

4. Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery;Breast Cancer Research and Treatment;2024-02-21

2. Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts;Cancer;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3